Metachromatic leukodystrophy in infant presenting as acute febrile illness: a case report

Santosh Acharya1, Binit Upadhaya Regmi2, Yuvraj Adhikari3

  • 1Chitwan Medical College and Teaching Hospital, Chitwan.

Abstract

Insights

Metachromatic leukodystrophy (MLD) is a rare genetic disorder causing neurological damage due to enzyme deficiency. This case underscores the critical need for early MLD diagnosis and comprehensive care for affected children.

Area of Science:

  • Neuroscience
  • Genetics
  • Rare Diseases

Background:

  • Metachromatic leukodystrophy (MLD) is a rare genetic disorder caused by arylsulfatase A (ARSA) enzyme deficiency.
  • This deficiency leads to the accumulation of sulfatides, resulting in damage to the central and peripheral nervous systems' myelin sheath.
  • Early diagnosis is critical for managing MLD, a condition with significant systemic effects.

Observation:

  • A 14-month-old male presented with symptoms including fever and painful urination, followed by rapid loss of motor and cognitive skills.
  • Diagnostic investigations confirmed MLD, further complicated by severe malnutrition.
  • Despite medical interventions, the patient experienced progressive deterioration, cardiopulmonary arrest, and ultimately, death.

Findings:

  • The case illustrates the diagnostic challenges associated with MLD, particularly its rapid progression and systemic manifestations like severe metabolic acidosis.
  • Magnetic Resonance Imaging (MRI) is a key diagnostic tool, but timely diagnosis is often hindered by the disease's swift decline.
  • Limited therapeutic options highlight the need for a multidisciplinary approach to patient care.

Implications:

  • This case emphasizes the importance of considering rare genetic disorders like MLD in cases of unexplained neurological regression in infants.
  • Increased awareness and improved diagnostic strategies are crucial for timely intervention and management of MLD.
  • The medical community's commitment to providing care and support for patients with devastating genetic disorders remains vital.